Patrick C Kung

Title: The Innovations of Patrick C Kung

Introduction

Patrick C Kung is a notable inventor based in Villanova, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has implications for both medical treatment and diagnostic applications.

Latest Patents

One of his latest patents involves the development of mammalian monoclonal antibodies against endotoxin of gram-negative bacteria. These antibodies are designed to react with lipopolysaccharides (LPS) across different genera of gram-negative bacteria. They hold promise for the treatment or prevention of gram-negative bacteremia and for the detection of gram-negative microorganisms. Another significant patent focuses on immunoassays for biologically active human interferon-gamma. This innovation includes rapid, sensitive, and accurate immunoassays based on monoclonal antibodies that specifically react with epitopes of the biologically active form of huIFN-gamma. These immunoassays are useful for detecting macrophage activation factors and include various assay types such as sandwich immunoradiometric assays and competitive binding assays.

Career Highlights

Patrick C Kung is currently associated with Centocor, Inc., where he continues to advance his research and innovations. His work has been instrumental in enhancing the understanding and treatment of various medical conditions related to gram-negative bacteria and interferon-gamma.

Collaborations

Throughout his career, Patrick has collaborated with notable colleagues, including Warren C Bogard, Jr. and Tse W Chang. These collaborations have contributed to the successful development of his patented technologies.

Conclusion

Patrick C Kung's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical diagnostics and treatment.